Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

480
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
480
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

315
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

315
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
315
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

392
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
392
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Development and External Validation of an Electronic Health Record-Derived Model for 30-Day Periprocedural Ischemic Stroke.

Journal of the American Heart Association·2026
Same author

Echocardiographic wall motion abnormalities in patients with stroke may warrant cardiac evaluation.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Impact of time to endovascular securement on outcomes in aneurysmal subarachnoid hemorrhage.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Impact of Circle of Willis Anatomical Variations on Outcomes in Aneurysmal Subarachnoid Hemorrhage.

Neurocritical care·2025
Same author

Correction: Risk Factors for Opioid Utilization in Patients with Intracerebral Hemorrhage.

Neurocritical care·2025
Same author

Corrigendum to "Level of consciousness at discharge and associations with outcome after ischemic stroke" [Journal of the Neurological Sciences, Volume 390 (2018): 102-107].

Journal of the neurological sciences·2025

Video Experimental Relacionado

Updated: Feb 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Prevención secundaria tras un ictus isquémico

Karen L Furie1, Peter J Kelly2,3

  • 1Warren Alpert Medical School of Brown University, Providence, RI.

The New England journal of medicine
|February 18, 2026
PubMed
Resumen
Este resumen es generado por máquina.

El manejo de los factores de riesgo modificables y el inicio temprano de la prevención secundaria del ictus pueden reducir el riesgo de ictus isquémico recurrente. La monitorización constante de las métricas de riesgo, el estilo de vida y los medicamentos es crucial para los resultados de los pacientes a largo plazo.

Palabras clave:
Prevención secundariaIctus isquémicoFactores de riesgoEstilo de vidaRecurrenciaSalud pública

Más Videos Relacionados

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.9K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K

Videos de Experimentos Relacionados

Last Updated: Feb 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.9K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K

Área de la Ciencia:

  • Neurología
  • Cardiología
  • Salud Pública

Sus antecedentes:

  • El ictus isquémico recurrente supone una importante carga para la salud.
  • La prevención secundaria del ictus es fundamental para el manejo del paciente.

Objetivo del estudio:

  • Describir las estrategias para reducir el riesgo de ictus isquémico recurrente.
  • Enfatizar la importancia de la prevención secundaria temprana y continua.

Principales métodos:

  • Revisión de las directrices actuales de prevención secundaria del ictus.
  • Análisis de los factores de riesgo modificables para el ictus isquémico.
  • Énfasis en las estrategias de prevención específicas del mecanismo.

Principales resultados:

  • El manejo eficaz de los factores de riesgo modificables reduce la recurrencia del ictus.
  • La instauración temprana de estrategias de prevención secundaria es vital.
  • La monitorización posterior al ictus de las métricas de riesgo, el estilo de vida y la medicación es esencial.

Conclusiones:

  • Es necesario un enfoque integral de la prevención secundaria del ictus.
  • La intervención oportuna y la monitorización continua mejoran los resultados del paciente.
  • El manejo de los factores de riesgo y la adherencia a los planes de prevención son clave para reducir el ictus isquémico recurrente.